Drastic Fluctuations in CABG Costs Across Hospitals

The price of coronary artery bypass grafting (CABG) varies widely across U.S. hospitals, according to a study published in the April 1 issue of The American Journal of Cardiology.

Bria D. Giacomino, DO, from the University of Iowa Carver College of Medicine in Iowa City, and colleagues obtained out-of-pocket price estimates for CABG from a random sample of 53 U.S. hospitals for a hypothetical patient without medical insurance. The price was compared to a “fair price” estimate from Healthcare Bluebook data, based on each hospital’s zip code, and the Society of Thoracic Surgeons composite CABG quality score and risk-adjusted mortality rate.

The researchers found that the mean price for CABG was $151,271 (range, $44,824 to $448,038). Geographic census region was weakly linked to price, but no associations were seen for price with other structural characteristics or CABG volume. Hospital price was also not associated with average reimbursement from major insurers within the same zip code, Society for Thoracic Surgeon composite quality score, or risk-adjusted CABG mortality.

“There was no correlation between price information obtained from hospitals and the average reimbursement from major insurers in the same market,” the authors write. “We also found no evidence to suggest that hospitals that charge higher prices provide better quality of care.”

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Patient In Bed

Recent Blog Posts

ecmo_keystone_perfusion

ECMO: Last-Resort Life Support Option Helped Majority of Critically Ill COVID-19 Patients Survive, Global Study Shows.

inc_5000

Keystone Perfusion Services, PC Makes Inc. Magazine’s List of 5000 Fastest-Growing Private Companies for Second Time.

keystone_ecmo

Approximation of Scimitar Vein to Atrial Septal Defect During Scimitar Syndrome Repair

5000_color stacked-1

Keystone Perfusion Services PC Ranks No. 1090 on the 2019 Inc. 5000 list of the nation’s fastest-growing private companies.